Navigation Links
Diagnosoft(R) Introduces Its Third MRI Analysis Innovation
Date:1/30/2009

MORRISVILLE, N.C. and PALO ALTO, Calif., Jan. 30 /PRNewswire/ -- Diagnosoft, Inc., an innovator in magnetic resonance (MR) image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease, has unveiled its newest software solution: Diagnosoft(R) SENC. Strain-encoding, or SENC, is a new MRI analysis technique that will help physicians measure regional contraction, or relaxation, of the heart's myocardium. Like Diagnosoft's other two software products, Diagnosoft(R) HARP(TM) and Diagnosoft(R) PLUS, Diagnosoft(R) SENC enables quantification of data to improve diagnosis and guide monitoring and treatment of coronary artery disease.

Developed by Dr. Nael Osman, a faculty member at Johns Hopkins University, SENC is now a proprietary product of Diagnosoft, Inc. According to Dr. Osman, co-founder of Diagnosoft, "Diagnosoft(R) SENC provides an objective way to assess regional variations in muscle contraction due to ischemia, myocardial infarction, or other causes. Moreover, Diagnosoft(R) SENC produces maps of regional function with high spatial resolution at a level of quality sufficient even for the thin wall of the right ventricle. As a result, the technique can reveal small regional anomalies in contractility within the wall."

Most cardiac MRI procedures require patients to hold their breath. However, SENC images can be acquired in a fraction of a second, mapping regional function with unprecedented speed, so it can be used in combination with tests and maneuvers that allow patients to breathe normally. That means SENC is suitable for stress testing of cardiac function, as well as other diagnostic tests.

Dr. Osman said new Diagnosoft(R) SENC is a great addition to a rich and unique product suite originated with Diagnosoft(R) HARP(TM), "While MR tagged images can be produced on most MRI systems, this pulse sequence has limited spatial resolution and takes time to acquire. SENC pulse sequence does not require a second step of image processing, as does analyzing tagged MR images, so it streamlines throughput and decision-making."

About Diagnosoft

Diagnosoft, Inc., based in North Carolina and California, is a privately held company specializing in image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease. One of its products, Diagnosoft HARP(TM), is distinguished as the first FDA 510k-cleared software designed for the analysis of tagged magnetic resonance images. The company is focused on improving physician workflow, quantifying decision-making, and enhancing research and drug development advances.

Company founders Dr. Nael Osman and Dr. Jerry Prince, developed HARP technology at Johns Hopkins University (JHU), where they are faculty members. Dr. Matthias Stuber, a company founder who is also on the JHU faculty, brings additional insight and imaging expertise to Diagnosoft. More information about the company's three MRI analysis software products, Diagnosoft(R) HARP(TM), Diagnosoft(R) Plus and new Diagnosoft(R) SENC, is available at www.diagnosoft.com.

Diagnosoft(R) is a registered trademark of Diagnosoft, Inc. HARP(R) is a registered trademark of Johns Hopkins University. Diagnosoft, Inc. disclaims any proprietary interest in the marks and names of others.

    Contact:
    Firas BenAchour
    1-919-388-9492


'/>"/>
SOURCE Diagnosoft, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
2. Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
3. CSC Introduces HealthSpace Advisor Benchmarking Tool
4. Anushka * Cellulite Clinic * Cosmedical Centre Introduces Next Generation Cellulite Treatment
5. Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications
6. Crest Whitestrips Introduces a Revolutionary New Teeth Whitening Technology
7. Activator Methods Introduces Web-Based Seminar Program
8. Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
9. NutriSystem Introduces My NutriSystem. My Way!(TM)
10. American Community Introduces Community Flex(TM), an Affordable Health Plan in Arizona and Indiana
11. Annual SNM MI summit introduces the clinical trials network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... with leading global lifestyle design firm kathy ireland® Worldwide for five additional years, ... Worldwide entered into an exclusive licensing agreement three years ago to design and ...
(Date:12/5/2016)... Louis, Missouri (PRWEB) , ... December 05, 2016 ... ... across ethnic, gender, and geographic lines. The goal of Castlewood Treatment Centers has ... disorder treatment accessible to as many people as possible. In that spirit, ...
(Date:12/5/2016)... ... December 05, 2016 , ... Florida ... Florida Hospital West Florida Region. McGuinness brings experience in executive leadership and clinical ... physicians and leaders. , In her new role, that officially begins December 12, ...
(Date:12/5/2016)... ... 2016 , ... Sabah Shah MD, MBA has joined the Retina Group of New York ... founded by James M. Maisel, MD and has been providing tertiary medical and surgical retinal ... legacy of surpassing expectations amongst her peers. Growing up in a family of doctors, ...
(Date:12/5/2016)... ... December 05, 2016 , ... Z-Medica, LLC, a leading ... with The American College of Surgeons (ACS) to provide basic bleeding control instructor ... Control Basic” course is a pilot program that fulfills the intent of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016 Research and Markets has announced the addition ... to 2021" report to their offering. ... , , The global spinal ... 2021, at a CAGR of 5.3% from 2016 to 2021. Factors such ... cases, increasing government spending on healthcare, and rising income levels are propelling ...
(Date:12/5/2016)... , December 5, 2016 ... to Deputy Chairman   ... selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative and ... been appointed as non-executive Chairman, effective January 1 st ... Mission Therapeutics as a non-executive Director in July 2015. ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology: